OPEN APP
Home / Industry / Manufacturing /  India's Hetero wins emergency use nod to make Roche's Covid drug

BENGALURU: Indian drug developer Hetero said on Monday that it has received emergency use approval from the country's health authorities to make a generic version of Roche Holding AG's COVID-19 drug.

This story has been published from a wire agency feed without modifications to the text. Only the headline has been changed.

Subscribe to Mint Newsletters
* Enter a valid email
* Thank you for subscribing to our newsletter.
Close
Recommended For You
×
Edit Profile
Get alerts on WhatsApp
Set Preferences My ReadsFeedbackRedeem a Gift CardLogout